Navigation Links
Astute Medical, Inc. organizará el 33. simposio anual en el congreso ISICEM sobre daño renal
Date:3/13/2013

una emergencia médica tan grave como un ataque al corazón", afirma el Dr. Claudio Ronco , director del departamento de Nefrología del Hospital San Bartolo de Vicenza, Italia. "Sin embargo, al contrario que los ataques al corazón, el DRA es silencioso, sin signos ni síntomas que indiquen riesgo de DRA. Si no se detecta ni se examina precozmente, el DRA pueden conllevar daños renales importantes que podrían afectar la calidad de vida, aumentar el riesgo de reingreso o incluso provocar la muerte".

El Dr. Ronco es el autor de un comentario reciente sobre el DRA en las unidades de  cuidados intensivos.

Astute Medical, Inc., que ha iniciado recientemente la comercialización en Europa del análisis NephroCheck® para la evaluación del riesgo de DRA, organizará el simposio. Astute Medical es un expositor del congreso ISICEM, la conferencia sobre medicina de cuidados críticos de mayor tamaño y más influyente del mundo, que cada año atrae a aproximadamente 6000 líderes de opinión, médicos y otros profesionales sanitarios. El estand de Astute Medical se puede encontrar en la sala principal de exposiciones, No. 2.65-2.68.

 

Astute Medical es un patrocinador del 2013 World Kidney Day, enfocado en el daño renal agudo (DRA).  A través de la campaña "Stop Kidney Attack!", la organización espera elevar la concienciación del DRA y estimular discusión, educación y legislación para mejorar la prevención y tratamiento de esta amenaza sanitaria a nivel mundial. Haga clic aquí para obtener más información.

La prueba NephroCheck® Test y el equipo Astute140™ no están
'/>"/>

SOURCE Astute Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Astute Medical, Inc. Advancing Next Generation Acute Kidney Injury Biomarkers
2. Astute Medical, Inc. promuove lultima generazione di biomarcatori per lesioni renali acute
3. Astute Medical, Inc. ospiterà il simposio sullinsufficienza renale al 33o incontro annuale ISICEM
4. Saladax Biomedical, Inc. to Present at Biotech Showcase™ 2012
5. Saladax Biomedical, Inc. Issued Six Patents Containing Broad Claims in the Immunoassay Space
6. MD+DI, the Global MedTech Industry Authority, Wins a 2012 Maggie for Best Cover in the Medical, Dental & Related Services/Trade Category
7. MD+DI, the Global MedTech Industry Authority, Wins a 2012 Maggie for Best Overall Category in Medical, Dental & Related Services/Trade
8. KAHR Medical, a Hadasit Bio-Holdings Portfolio Company, to Raise $2.6 Million
9. Saladax Biomedical, Inc. Announces the Formation of a CLIA Laboratory As Part of the Companys Commercialization Strategy
10. R&D, Innovation Key to Success - Research Report on Varian Medical Systems, Inc., Boston Scientific Corporation, Stryker Corporation, St. Jude Medical, Inc., and Thermo Fischer Scientific Inc.
11. SFJ Pharma Ltd. II, Announces Agreement With Pfizer to Develop Axitinib for Adjuvant Treatment of Renal Cell Carcinoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... SPRINGS, Florida , March 2, 2015 /PRNewswire/ ... science-based pharmaceuticals and healthy whole food nutrition products ... treatments of lifestyle related disorders such as hyperglycemia, ... and health concerns.  Nutraceutical and Biotech Companies in ... ), Amira Nature Foods Ltd. (NYSE: ...
(Date:3/2/2015)... Sterlitech is proud to debut its multi-line, ... 2015 AMTA Membrane Technology Conference in Orlando. This ... of engineering and customer feedback, which has resulted in ... applications across an array of disciplines. It is ... needs of researchers and engineers alike and is ideal ...
(Date:2/28/2015)... Increasing its efforts to resolve the GMO ... episodes of The GMO TRUTH podcast on both ITunes and ... continues its mission to discover the truth and change the ... “uncover the truth about the GMOs in our food supply,” ... Podcast is an expansion of the documentary/investigative film-making methodology in ...
(Date:2/27/2015)... 2015 A paper published today, " ... " in Science Translational Medicine, demonstrates ... reduce the risk associated with investing in the ... levels of funding for developing so-called "orphan" drugs. ... collaboration between scientists at the National Center for ...
Breaking Biology Technology:Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 2Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 3Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 4Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 5Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 6Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 7Sterlitech Displays Complete CF042 Membrane Test System 2The Walk a Mile Project Launches “GMO Truth” Podcast 2New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 2New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 3New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 4
... (Nasdaq: MITI ), a biopharmaceutical company developing novel, proprietary ... announced that it will host a webcast on June 8, 2009 ... at the 14th Congress of the European Hematology Association. The ... www.micromet-inc.com . , , Forum: ...
... ... software code bases. In this Software Technology Report, Full Spectrum Software offers a guide to ... for your medical device. You can download the report here . A must read ... ...
... to revolutionize the world of sensors: motion, chemical, temperature, ... down to the nano requires finding a means to ... In a paper appearing in Nano Letters ... of MIT,s Department of Civil and Environmental Engineering say ...
Cached Biology Technology:Micromet to Host Conference Call and Webcast to Discuss Blinatumomab Data Presented at EHA on June 8, 2009 2Micromet to Host Conference Call and Webcast to Discuss Blinatumomab Data Presented at EHA on June 8, 2009 3Micromet to Host Conference Call and Webcast to Discuss Blinatumomab Data Presented at EHA on June 8, 2009 4For Medical Device Makers, a New Software Technology Report, Time to Get Rid of Your Old Code from Full Spectrum Software 2For Medical Device Makers, a New Software Technology Report, Time to Get Rid of Your Old Code from Full Spectrum Software 3Biomimetic-engineering design can replace spaghetti tangle of nanotubes in novel material 2
(Date:2/11/2015)... , February 11, 2015 ... research report "Access Control Market by Product (Cards and ... Residential, Military and Defense, Government, Industrial, Healthcare, Education) and ... published by MarketsandMarkets, the Access Control Market ... 2020, growing at a CAGR of 10.6% ...
(Date:2/5/2015)... 2015   Epic Sciences , a precision diagnostics company ... Murali Prahalad , Ph.D., president and CEO, is scheduled ... (PMWC) 2015: Silicon Valley, which is taking place at the ... on January 26-28, 2015. Dr. Prahalad ... Biomarkers." Last year, Epic Sciences was a finalist in the ...
(Date:2/5/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/6lngtl/global_biometrics ) ... Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, ... their offering. , In global ... anticipated to overtake North America ... towards IT security, government biometric based projects such ...
Breaking Biology News(10 mins):Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4Epic Sciences to Present at Personalized Medicine World Conference 2015 on the Use of Circulating Tumor Cells as Cancer Biomarkers 2Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 2Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 3
... Switzerland June 7, 2008 The Cancer and ... phase II clinical trial showing that 70 percent of ... with galiximab, an investigational anti-CD80 monoclonal antibody, when given ... the study, 44 percent achieved a complete response and ...
... who dig dinosaurs in Eastern Montana will now be ... excavated and before degrading begins. Paleontologists from Montana ... Carolina Museum of Natural Sciences recently bought and renovated ... to Eastern Montana for the summer. The lab ...
... Media Fellows, Wendy Hansen and Maddalena Jackson, are ... part of a 10-week internship from June to August ... Wendy Hansen is a biophysics Ph.D. candidate ... 2008 graduate of Harvey,Mudd College, Claremont, Calif., with a ...
Cached Biology News:Galiximab in combination with rituximab in patients with previously untreated follicular lymphoma 2Dinosaur diggers bring mobile lab, new techniques to Eastern Montana 2Dinosaur diggers bring mobile lab, new techniques to Eastern Montana 3
5(S)-HETE-d8 is used as an internal standard for the quantification of 5(S)-HETE by stable isotope dilution mass spectrometry....
Full-length cDNA clone CS0DJ013YG01 of T cells (Jurkat cell line) of Homo sapiens (human). [Source:Uniprot/SPTREMBL;Acc:Q86SZ3] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
...
...
Biology Products: